THORACIC ATYPICAL HEMANGIOMAS: DIAGNOSIS AND MANAGEMENT-A SINGLE CENTER EXPERIENCE
PDF
Cite
Share
Request
ORIGINAL ARTICLE
VOLUME: 36 ISSUE: 3
P: 98 - 102
July 2025

THORACIC ATYPICAL HEMANGIOMAS: DIAGNOSIS AND MANAGEMENT-A SINGLE CENTER EXPERIENCE

J Turk Spinal Surg 2025;36(3):98-102
1. Gözde İzmir Hospital, Clinic of Neurosurgery, İzmir, Türkiye
2. İstinye University Faculty of Medicine, Department of Neurosurgery, İstanbul, Türkiye
No information available.
No information available
Received Date: 25.03.2025
Accepted Date: 17.06.2025
Online Date: 08.07.2025
Publish Date: 08.07.2025
PDF
Cite
Share
Request

ABSTRACT

Objective

Vertebral hemangiomas (VH) are common benign vascular tumors, often discovered incidentally. However, the clinical significance and optimal management of atypical VH, particularly in the thoracic region, remain unclear due to their variable radiological appearances and overlapping features with malignant lesions. This study aims to investigate the diagnosis, radiological characteristics, and management strategies of atypical thoracic VH.

Materials and Methods

A retrospective review was conducted on 3,175 spinal magnetic resonance imaging (MRI) reports performed at our center between January 2019 and September 2023. Patients with radiological findings suggestive of atypical thoracic VH were identified, and imaging was re-evaluated by two experienced neuroradiologists. Patients were included if radiological criteria for atypical VH were met and follow-up data were available. Demographic data, lesion characteristics, imaging findings, and clinical outcomes were recorded.

Results

A total of 41 patients (26 female, 15 male; mean age: 47.7 years) with atypical thoracic VH were included. Most lesions showed hypointensity on T1-weighted images and hyperintensity on T2-weighted and short tau inversion recovery sequences. Lesions were most commonly located at T7, and 71% were solitary. Additional imaging, including computed tomography (CT), contrast-enhanced MRI, and positron emission tomography-CT, was performed in select cases to exclude malignancy. No cases exhibited extraosseous extension or radiological progression during a mean follow-up of 49 months. Of 13 patients presenting with back pain, 69% improved with conservative management. No patients developed neurological deficits or required surgical intervention.

Conclusion

Atypical thoracic VH may present with imaging characteristics that mimic malignancy but often remain clinically silent and stable over time. Accurate radiological assessment and close follow-up are essential to avoid unnecessary interventions. Observation appears to be a safe and appropriate strategy for managing asymptomatic atypical VH.

Keywords:
Atypical, spinal, thoracic, vertebral hemangioma

INTRODUCTION

Vertebral hemangiomas (VH) are incidental findings and relatively common radiological entities. As a benign vascular tumor, VH is one of the most common spinal tumors, with an estimated incidence in the general population ranging from 1% to 30%(1-4). The male-to-female ratio varies between 1:1.2 and 1:2.25(5-7). Multiple perspectives exist regarding the symptomatic evolution of atypical hemangiomas. While some studies suggest that atypical hemangiomas are merely a radiological diagnosis and do not exhibit aggressive features, others emphasize that the atypical form is a significant factor for progression to the aggressive type(2, 5, 8). Similarly, conflicting findings are observed in terms of hormonal effects, diagnosis, treatment, symptomatic presentation, and neurological deficits(9-12). Almost every aspect of VH reported in the literature shows widely varying rates, leading to significant uncertainty. Consequently, the management of atypical thoracic hemangiomas remains incompletely understood. In our study, we retrospectively analyzed patients diagnosed and followed up with atypical thoracic hemangiomas in our clinic. The aim of this study is to determine the diagnosis and management of thoracic hemangiomas with atypical features on magnetic resonance imaging (MRI).

MATERIALS AND METHODS

All records of spinal MRI performed at our center between January 2019 and September 2023 were retrospectively reviewed. A text search was conducted in the reports using the keywords “atypical hemangioma(s)” and “atypical VH(s).” All spinal MRI studies performed at our center were initially reported as part of routine clinical practice by two neuroradiologists with over 10 years of experience in neuroradiology. The images of patients suspected of having atypical VH were independently re-evaluated by the same two radiologists, and the final diagnosis was established by mutual consensus. This standardized evaluation process minimized interobserver variability and ensured that only lesions meeting the accepted radiological criteria for atypical hemangiomas were included in the study.

Inclusion criteria were: (1) availability of thoracic spinal MRI with a prospective or suspected diagnosis of atypical hemangioma; (2) confirmation of radiological features consistent with atypical hemangiomas upon expert re-evaluation; and (3) availability of follow-up imaging or clinical documentation.

Exclusion criteria included: (1) inconclusive imaging findings; (2) absence of follow-up records; and (3) contraindications to MRI or patient refusal of follow-up evaluation.

If the patients’ MRIs were consistent with the radiological findings of atypical thoracic hemangiomas, further investigations, including computed tomography (CT), contrast-enhanced thoracic MRI, and positron emission tomography-CT (PET-CT), as well as clinical follow-up notes, were examined.

Demographic characteristics of the patients, lesion location and appearance, number of lesions, compression of neural elements, neurological examination findings, and follow-up results were recorded. Neurological examination findings were retrospectively obtained from electronic medical records and included in the analysis only if they were systematically documented during initial or follow-up visits. The study was approved by İstinye University Faculty of Medicine Human Research Ethics Committee (decision number: 24-213, date: 22.12.2024).

Statistical Analysis

Statistical analyses were performed using SPSS (version 22.0, IBM Corp., Armonk, NY). Descriptive statistics were presented as mean ± standard deviation or median (minimum-maximum), depending on the data distribution.

RESULTS

A text search of 3175 MRI examinations conducted at İstinye University Hospital Medical Park Gaziosmanpaşa between January 2019 and September 2023 identified 93 records with relevant keywords. Fourteen cases with lumbar and eleven with cervical atypical hemangiomas were excluded from the study. Among the remaining 68 cases, 19 were found to have thoracic metastases upon further evaluation. Six cases initially reported as atypical hemangiomas were excluded because their radiological findings did not meet the criteria for atypical hemangiomas. Two patients who did not continue follow-up after diagnosis were also excluded. A total of 41 patients met the inclusion criteria and were included in the study. The mean age of the patients was 47.68 years, ranging from 26 to 78 years. The study population included 26 (63%) female and 15 male patients (Table 1). Nineteen patients had no neurosurgical complaints, while 14 (34%) reported back pain, 5 had lower back pain, and 3 had neck pain. Lesions located at the T1 or T12 vertebrae were incidentally detected in cervical or lumbar MRI scans of 6 patients. In these cases, the adjacent thoracic vertebral levels (T1 or T12) were partially included in the imaging field, allowing for lesion identification, which was later confirmed with dedicated thoracic imaging. On T1-weighted images, 32 (78%) cases showed low signal intensity, and 9 exhibited mixed signals, while high signal intensity was observed on T2-weighted and short tau inversion recovery sequences in 39 (95%) cases (Figure 1). Upon repeated radiological evaluation, an additional atypical hemangioma was detected in 4 patients. Twenty-nine patients (71%) presented with a single lesion, while six patients had two lesions, five patients had three lesions, and one patient exhibited four atypical hemangiomas. The most frequently affected vertebra was T7, observed in 9 (22%) patients. The least affected vertebrae were T3, T5 and T9 with two cases each (Figure 2). Among patients with a single lesion, neither the T3 nor the T5 vertebra was solely affected. Additionally, 15 (37%) patients had typical hemangiomas in the thoracic region. The size of atypical hemangiomas ranged from 2 to 26 mm in maximum diameter, and in 8 (20%) cases, the lesion size exceeded 1 cm. Only 1 case showed involvement of more than 50% of the vertebral body (VB). In 39 (95%) cases, the lesions were confined to the VB. One case had a lesion in the left pedicle, and another with multiple atypical hemangiomas exhibited a lesion extending from the VB to the left pedicle. No extraosseous extension was observed in any case. To confirm the radiological diagnosis, thoracic CT was performed in 26 patients, contrast-enhanced thoracic MRI in 29 patients, and PET-CT in 2 patients. Radiological findings of atypical hemangiomas were observed in 11 patients on CT (Figure 3). On contrast-enhanced thoracic MRI, contrast enhancement was detected in 4 patients (Figure 4). PET-CT revealed cold lesions in 2 patients, ruling out metastasis. Patients with a history of cancer, symptomatic presentation, or contrast enhancement underwent their first follow-up at 6 months, which included both CT and MRI. For other patients, annual follow-ups were conducted with thoracic MRI alone. The mean follow-up duration was 49 months (17-68 months). No progression was observed in any patient. Among the 13 patients with back pain, 9 (69%) experienced pain resolution following conservative treatment. The remaining 4 reported pain unrelated to the lesion’s localization. In a patient diagnosed with endometrial cancer, pathological fractures were identified in the lumbar 3, 4, and 5 VB during follow-up, leading to vertebroplasty.

DISCUSSION

In this retrospective single-center study, 41 cases of atypical VH were identified, corresponding to an incidence of 1.3%. Reassessment of available imaging revealed additional lesions in four patients, suggesting that smaller or less conspicuous VH may be underrecognized in routine radiological or autopsy studies. This finding supports the hypothesis that the increasing use of advanced imaging techniques contributes to higher detection rates(4, 7, 13, 14). Most lesions were located in the thoracic spine, followed by the lumbar and cervical regions, while no lesions were observed in the sacrum. Approximately 15% of thoracic VH located at T1 or T12 were incidentally detected on cervical or lumbar spine MRI, emphasizing the importance of thoroughly evaluating all visible vertebral levels, even when not the primary focus of imaging(11, 12). The anatomical distribution observed in this cohort is consistent with prior reports indicating a predilection for the mid-and lower thoracic segments(15, 16). The mean age of patients was 47.7 years, aligning with previous literature that describes VH as most frequently diagnosed in individuals aged 40-60 years(17). A predominance of female patients was also noted, consistent with earlier studies suggesting a possible hormonal influence on lesion development(7, 15, 18, 19). However, due to the retrospective nature of the study, hormonal status could not be assessed. VH are often incidental findings and typically asymptomatic. In this cohort, no patients exhibited neurological deficits or other symptoms directly attributable to VH. Symptomatic cases, although rare, may present with localized pain or signs of neural compression(3). In our series, 70% of patients presenting with back pain reported symptomatic relief during follow-up, and in four cases, pain localization did not correlate with the location of the VH, suggesting an incidental relationship. VH can be classified as typical, atypical, or aggressive based on radiological and clinical features(1, 5, 6). Typical VH exhibit high signal intensity on both T1-and T2-weighted MRI due to their fat-rich composition, whereas atypical VH demonstrate iso- to hypointense T1 signals and markedly hyperintense T2 signals, often lacking classic imaging signs such as the “corduroy” or “polka-dot” appearance(2, 6, 8, 11, 20). The presence of thickened vertical trabeculae remains a key diagnostic criterion, observable on both CT and MRI. CT features characteristic of atypical VH were observed in 35% of patients in this study, aligning with previous estimates indicating that atypical forms constitute approximately one-third of all VH(15). Aggressive VH may exhibit expansion, cortical destruction, epidural or paravertebral extension, vertebral collapse, or neurological symptoms(9). Lesions with greater vascularity tend to be more symptomatic and progressive, in contrast to asymptomatic, fat-dominant VH(2, 3). Atypical and aggressive VH may mimic malignant spinal lesions such as metastases or multiple myeloma, complicating the differential diagnosis(9, 10, 21). Advanced imaging modalities, including CT, MRI, and PET-CT, are critical for accurate lesion characterization. PET-CT is particularly useful in differentiating VH from metastatic lesions based on metabolic activity(22, 23). In this study, two patients with prior oncological diagnoses underwent PET-CT scans that demonstrated metabolically inactive (“cold”) lesions, and subsequent follow-up confirmed the benign nature of these findings(24-27). The signal characteristics of symptomatic VH-low T1 and high T2 intensity-are often associated with vascular, biologically active lesions, as originally described by Laredo et al.(2) However, previous studies have shown that VH, including atypical and aggressive forms, often remain radiologically stable and asymptomatic over time(16). Misdiagnosis of atypical VH as malignant lesions has led to unnecessary interventions and patient anxiety. Consequently, some authors have advocated replacing the term “atypical hemangioma” with “lipid-poor hemangioma” to better reflect the radiological rather than clinical behavior of these lesions(8). In our cohort, no radiological progression or new-onset neurological deficits were observed during follow-up, even in lesions with low fat content. Management strategies for symptomatic VH include conservative measures, percutaneous interventions (e.g., vertebroplasty, sclerotherapy), surgery, radiotherapy, or combined approaches(3, 28). Surgical treatment is typically reserved for cases with neurological compromise, pathologic fractures, or intractable pain. CT-guided biopsy and PET-CT may be considered in diagnostically uncertain or atypical cases(29). However, biopsy is infrequently performed due to limited diagnostic yield and potential risks such as bleeding or epidural hematoma(4, 24). Therefore, non-invasive imaging modalities remain the cornerstone of diagnosis.

Study Limitations

The primary limitations of this study include its retrospective design and single-center setting, which may introduce selection and observer bias and limit generalizability. Furthermore, the absence of long-term follow-up and the relatively small sample size preclude definitive conclusions regarding the natural history of atypical VH.

CONCLUSION

VH are typically asymptomatic lesions incidentally detected during routine spinal imaging. Our study demonstrates that observation-based management of asymptomatic atypical VH is a safe and appropriate approach. While atypical VH may exhibit different radiological signal characteristics, this does not always necessitate suspicion of malignancy. Proper assessment of the clinical significance of various VH types, despite the radiological diversity in signal changes, can help avoid unnecessary radiological follow-ups, invasive biopsies, and outpatient clinic visits. Moreover, this approach contributes to preventing undue anxiety and stress among patients. In conclusion, careful clinical evaluation is sufficient to prevent unnecessary interventions for asymptomatic VH.

Ethics

Ethics Committee Approval: The study was approved by İstinye University Faculty of Medicine Human Research Ethics Committee (decision number: 24-213, date: 22.12.2024).
Informed Consent: Retrospective study.

Authorship Contributions

Surgical and Medical Practices: H.K., Concept: B.B., H.K., Design: B.B., H.K., Data Collection or Processing: B.B., H.K., Analysis or Interpretation: B.B., Literature Search: B.B., H.K., Writing: B.B., H.K.
Conflict of Interest: The authors have no conflicts of interest to declare.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Jiang L, Liu XG, Yuan HS, Yang SM, Li J, Wei F, et al. Diagnosis and treatment of vertebral hemangiomas with neurologic deficit: a report of 29 cases and literature review. Spine J. 2014;14:944-54.
2
Laredo JD, Assouline E, Gelbert F, Wybier M, Merland JJ, Tubiana JM. Vertebral hemangiomas: fat content as a sign of aggressiveness. Radiology. 1990;177:467-72.
3
Teferi N, Chowdhury AJ, Mehdi Z, Challa M, Eschbacher K, Bathla G, et al. Surgical management of symptomatic vertebral hemangiomas: a single institution experience and literature review. Spine J. 2023;23:1243-54.
4
Zafeiris CP, Lewkonia P, Jacobs WB. Atypical vertebral hemangioma: an aggressive form of a benign disease. Case Report and Literature Review. J Musculoskelet Neuronal Interact. 2021;21:317-21.
5
Cloran FJ, Pukenas BA, Loevner LA, Aquino C, Schuster J, Mohan S. Aggressive spinal haemangiomas: imaging correlates to clinical presentation with analysis of treatment algorithm and clinical outcomes. Br J Radiol. 2015;88:20140771.
6
Gaudino S, Martucci M, Colantonio R, Lozupone E, Visconti E, Leone A, et al. A systematic approach to vertebral hemangioma. Skeletal Radiol. 2015;44:25-36.
7
Slon V, Stein D, Cohen H, Sella-Tunis T, May H, Hershkovitz I. Vertebral hemangiomas: their demographical characteristics, location along the spine and position within the vertebral body. Eur Spine J. 2015;24:2189-95.
8
Hoyle JM, Layfield LJ, Crim J. The lipid-poor hemangioma: an investigation into the behavior of the “atypical” hemangioma. Skeletal Radiol. 2020;49:93-100.
9
Cross JJ, Antoun NM, Laing RJ, Xuereb J. Imaging of compressive vertebral haemangiomas. Eur Radiol. 2000;10:997-1002.
10
Alexander J, Meir A, Vrodos N, Yau YH. Vertebral hemangioma: an important differential in the evaluation of locally aggressive spinal lesions. Spine (Phila Pa 1976). 2010;35:E917-20.
11
Acosta FL Jr, Sanai N, Chi JH, Dowd CF, Chin C, Tihan T, et al. Comprehensive management of symptomatic and aggressive vertebral hemangiomas. Neurosurg Clin N Am. 2008;19:17-29.
12
Wang B, Zhang L, Yang S, Han S, Jiang L, Wei F, et al. Atypical Radiographic features of aggressive vertebral hemangiomas. J Bone Joint Surg Am. 2019;101:979-86.
13
Huvos AG. Hemangioma, lymphangioma, angiomatosis/lymphangiomatosis, glomus tumor. In: Huvos AG (Ed.). Bone Tumors: Diagnosis, Treatment, and Prognosis. 2nd ed. Saunders, Philadelphia 1991; pp:553-78.
14
Barzin M, Maleki I. Incidence of vertebral hemangioma on spinal magnetic resonance imaging in Northern Iran. Pak J Biol Sci. 2009;12:542-4.
15
Zhang L, Wang B, Han S, Yang S, Jiang L, Yuan H, et al. Imaging features and atypical signs of symptomatic vertebral haemangioma: a retrospective single-centre analysis of 118 patients. Br J Radiol. 2021;94:20201250.
16
Abul-Kasim K, Persson E, Levinsson A, Strömbeck A, Selariu E, Ohlin A. Vertebral hemangiomas: prevalence, new classification and natural history. Magnetic resonance imaging-based retrospective longitudinal study. Neuroradiol J. 2023;36:23-30.
17
Campanacci M. Hemangioma. In: Campanacci M (Ed.). Bone and soft tissue tumors. Piccin Nuova Libraria & Springer, Padova & Wien 1999;599-618. Available from: https://doi.org/10.1007/978-3-7091-3846-5_36
18
Vijay K, Shetty AP, Rajasekaran S. Symptomatic vertebral hemangioma in pregnancy treated antepartum. A case report with review of literature. Eur Spine J. 2008;17(Suppl 2):S299-303.
19
Roelvink NC, Kamphorst W, August H, van Alphen M, Rao BR. Literature statistics do not support a growth stimulating role for female sex steroid hormones in haemangiomas and meningiomas. J Neurooncol. 1991;11:243-53.
20
Hanrahan CJ, Christensen CR, Crim JR. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Radiographics. 2010;30:127-42.
21
Blankstein A, Spiegelmann R, Shacked I, Schinder E, Chechick A. Hemangioma of the thoracic spine involving multiple adjacent levels: case report. Paraplegia. 1988;26:186-91.
22
Choi YY, Kim JY, Yang SO. PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions. Semin Musculoskelet Radiol. 2014;18:133-48.
23
Brogsitter C, Hofmockel T, Kotzerke J. (68)Ga DOTATATE uptake in vertebral hemangioma. Clin Nucl Med. 2014;39:462-3.
24
Paladino LP, Belzarena AC, Henderson-Jackson E, Joyce DM. Metastatic vertebral lesion mimicking an atypical hemangioma with negative 18F-FDG positron emission tomography-computed tomography. Radiol Case Rep. 2019;14:1401-6.
25
Morales KA, Arevalo-Perez J, Peck KK, Holodny AI, Lis E, Karimi S. Differentiating atypical hemangiomas and metastatic vertebral lesions: the role of T1-weighted dynamic contrast-enhanced MRI. AJNR Am J Neuroradiol. 2018;39:968-73.
26
Winfield JM, Poillucci G, Blackledge MD, Collins DJ, Shah V, Tunariu N, et al. Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI. Eur Radiol. 2018;28:1687-91.
27
Matrawy K, El-Nekeidy AM, El-Sheridy HG. Atypical hemangioma and malignant lesions of the spine: can diffusion-weighted magnetic resonance imaging help to differentiate? Egypt J Radiol Nucl Med. 2013;44:259-63.
28
Doppman JL, Oldfield EH, Heiss JD. Symptomatic vertebral hemangiomas: treatment by means of direct intralesional injection of ethanol. Radiology. 2000;214:341-8.
29
Kato K, Teferi N, Challa M, Eschbacher K, Yamaguchi S. Vertebral hemangiomas: a review on diagnosis and management. J Orthop Surg Res. 2024;19:310.